Cryosite Competitors

Cryosite (ASX:CTE) and (BUX) (CNSX:BUX) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Cryosite and (BUX), as provided by MarketBeat.com.

Profitability

This table compares Cryosite and (BUX)'s net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Cryosite and (BUX)'s gross revenue, earnings per share (EPS) and valuation.

Cryosite has higher revenue and earnings than (BUX).

Summary

Cryosite beats (BUX) on 1 of the 1 factors compared between the two stocks.

Cryosite (ASX:CTE) and 12144 (CNSX:IME) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Analyst Recommendations

This is a summary of current ratings for Cryosite and 12144, as reported by MarketBeat.com.

Profitability

This table compares Cryosite and 12144's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Cryosite and 12144's revenue, earnings per share and valuation.

Cryosite has higher revenue and earnings than 12144.

Summary

Cryosite beats 12144 on 1 of the 1 factors compared between the two stocks.

Cryosite (ASX:CTE) and BARD1 Life Sciences (ASX:BD1) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Profitability

This table compares Cryosite and BARD1 Life Sciences' net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current ratings for Cryosite and BARD1 Life Sciences, as reported by MarketBeat.com.

Earnings & Valuation

This table compares Cryosite and BARD1 Life Sciences' revenue, earnings per share and valuation.

Cryosite has higher revenue and earnings than BARD1 Life Sciences.

Summary

Cryosite beats BARD1 Life Sciences on 3 of the 3 factors compared between the two stocks.

Cryosite (ASX:CTE) and Charles River Laboratories International (CNSX:CRL) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Earnings and Valuation

This table compares Cryosite and Charles River Laboratories International's revenue, earnings per share and valuation.

Cryosite has higher revenue and earnings than Charles River Laboratories International.

Profitability

This table compares Cryosite and Charles River Laboratories International's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current recommendations and price targets for Cryosite and Charles River Laboratories International, as reported by MarketBeat.

Summary

Cryosite beats Charles River Laboratories International on 1 of the 1 factors compared between the two stocks.

dorsaVi (ASX:DVL) and Cryosite (ASX:CTE) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation.

Earnings & Valuation

This table compares dorsaVi and Cryosite's top-line revenue, earnings per share (EPS) and valuation.

Cryosite has higher revenue and earnings than dorsaVi.

Profitability

This table compares dorsaVi and Cryosite's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current ratings and price targets for dorsaVi and Cryosite, as provided by MarketBeat.com.

Summary

Cryosite beats dorsaVi on 3 of the 3 factors compared between the two stocks.

Cryosite (ASX:CTE) and Epigenomics (OTCMKTS:EPGNY) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings.

Profitability

This table compares Cryosite and Epigenomics' net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Cryosite and Epigenomics, as reported by MarketBeat.

Earnings and Valuation

This table compares Cryosite and Epigenomics' gross revenue, earnings per share (EPS) and valuation.

Cryosite has higher revenue and earnings than Epigenomics.

Summary

Cryosite beats Epigenomics on 1 of the 1 factors compared between the two stocks.